Benign meningiomas (WHO Grade I) with atypical histological features: Correlation of histopathological features with clinical outcomes

Journal of Neurosurgery

Volumn 124, Issue 1, 2016, Pages 106-114

  Marciscano, Ariel E ^a   Stemmer Rachamimov, Anat O ^b   Niemierko, Andrzej ^b   Larvie, Mykol ^b   Curry, William T ^b   Barker, Fred G ^b   Martuza, Robert L ^b   McGuone, Declan ^b   Oh, Kevin S ^b   Loeffler, Jay S ^b   Shih, Helen A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atypia; Atypical; Benign; Histopathological; Meningioma; Oncology; Simpson grade

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER RISK; CANCER SURGERY; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE DURATION; FEMALE; FOLLOW UP; HISTOLOGY; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKULL IRRADIATION; STEREOTACTIC RADIOSURGERY; TUMOR RECURRENCE; TUMOR VOLUME; VERY ELDERLY; WORLD HEALTH ORGANIZATION; ADJUVANT RADIOTHERAPY; DISEASE COURSE; EPIDEMIOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84973402333     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2015.1.JNS142228     Document Type: Article

References (32)

1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin- Hanjani S, Martuza RL, et al: Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56-60, 2009
2. Backer-Groøndahl T, Moen BH, Torp SH: The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 5:231-242, 2012
3. Barbera S, San Miguel T, Gil-Benso R, Muñoz-Hidalgo L, Roldan P, Gonzalez-Darder J, et al: Genetic changes with prognostic value in histologically benign meningiomas. Clin Neuropathol 32:311-317, 2013
4. Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, et al: Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75:399-406, 2009
5. Combs SE, Schulz-Ertner D, Debus J, von Deimling A, Hartmann C: Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys 81:1415-1421, 2011
6. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton AL: Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 39:427-436, 1997
7. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al: Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37:177-188, 1998
8. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195-201, 1994
9. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH: Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 46:57-61, 2000
10. Ho DM, Hsu CY, Ting LT, Chiang H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547, 2002
11. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al: Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151-160, 2000
12. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1986
13. Ko KW, Nam DH, Kong DS, Lee JI, Park K, Kim JH: Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci 14:747-753, 2007
14. Louis DN, Scheitauer BW, Budka H, Von Deimling A, Kepes JJ: Meningiomas, in Kleiues P, Cavenee WK (eds): World Health Organization Classification of Tumours. Pathology and Genetics. Tumors of the Nervous System. Lyon, France: IARC Press, 2000, pp 176-184
15. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
16. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, et al: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504-510, 1996
17. Modha A, Gutin PH: Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538-550, 2005
18. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M: MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176-3189, 1994
19. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al: CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol 15 (Suppl 2):ii1-ii56, 2013
20. Oya S, Kawai K, Nakatomi H, Saito N: Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 117:121-128, 2012
21. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Longterm prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86:793-800, 1997
22. Pearson BE, Markert JM, Fisher WS, Guthrie BL, Fiveash JB, Palmer CA, et al: Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 24(5):E3, 2008
23. Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao ST, Barnett GH, et al: Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427-432, 2009
24. Saraf S, McCarthy BJ, Villano JL: Update on meningiomas. Oncologist 16:1604-1613, 2011
25. Simon M, Boström J, Koch P, Schramm J: Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77:767-773, 2006
26. Soyuer S, Chang EL, Selek U, Shi W, Maor MH, DeMonte F: Radiotherapy after surgery for benign cerebral meningioma. Radiother Oncol 71:85-90, 2004
27. Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, et al: The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg 113:1029-1035, 2010
28. Taylor BW Jr, Marcus RB Jr, Friedman WA, Ballinger WE Jr, Million RR: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299-304, 1988
29. Trembath D, Miller CR, Perry A: Gray zones in brain tumor classification: evolving concepts. Adv Anat Pathol 15:287-297, 2008
30. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, et al: Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48:1363-1370, 2000
31. Whittle IR, Smith C, Navoo P, Collie D: Meningiomas. Lancet 363:1535-1543, 2004
32. Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D: The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31:141-149, 2005